Sandoz Group AG

OTCPK:SDZXF

Zwitserland / Gezondheidszorg / Farmaceutica

Overzicht

Dividenden

Historische financiële data 5 J

Aandelenkoers

41,36 USD


Key Metrics	Latest
Total Revenue	10,384 B
Adjusted EBITDA	734 M
EBITDA Margin	7,1%
Net Profit Margin	0,0%
Total Assets	19,907 B
Total Debt	4,869 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months	Dec-23	Dec-24

Revenue	9,658.00	9,678.00	9,306.00	9,979.00	10,384.00	10,384.00	9,979.00	10,384.00
% Growth		0.00	(0.04)	0.07	0.04			0.04

Adjusted EBITDA	1,450.00	1,840.00	1,660.00	794.00	734.00	734.00	794.00	734.00
% Margin	0.15	0.19	0.18	0.08	0.07	0.07	0.08	0.07

Adjusted EBIT	802.00	1,394.00	1,239.00	375.00	307.00	307.00	375.00	307.00
% Margin	0.08	0.14	0.13	0.04	0.03	0.03	0.04	0.03

Adjusted Net Income	464.00	910.00	863.32	87.40	(1.96)	(1.96)	87.40	(1.96)
% Margin	0.05	0.09	0.09	0.01	(0.00)	(0.00)	0.01	(0.00)

Adjusted Basic EPS	NA	NA	2.01	0.20	(0.00)	(0.00)	0.20	(0.00)

Ondersteunende berekeningen

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Original
USD	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	9,658	9,678	9,306	9,979	10,384	10,384	9,979	10,384
% Growth	NA	0.2%	-3.8%	7.2%	4.1%			4.1%

Cost of Revenue	(5,199)	(5,079)	(4,928)	(5,415)	(5,458)	(5,458)	(5,415)	(5,458)
Gross Profit	4,459	4,599	4,378	4,564	4,926	4,926	4,564	4,926
% Revenue	46.2%	47.5%	47.0%	45.7%	47.4%	47.4%	45.7%	47.4%

Research and Development	(873)	(911)	(49)	(41)	(26)	(26)	(41)	(26)
Selling and Marketing	0	0	0	0	0	0	0	0
General and Admin	(2,132)	(2,127)	(2,127)	(2,389)	(2,433)	(2,433)	(2,389)	(2,433)
Other Inc / (Exp)	(679)	(188)	(1,019)	(1,833)	(2,270)	(2,270)	(1,833)	(2,270)
Total Operating Exp	(3,684)	(3,226)	(3,195)	(4,263)	(4,729)	(4,729)	(4,263)	(4,729)

Operating Income	775	1,373	1,183	301	197	197	301	197
% Revenue	8.0%	14.2%	12.7%	3.0%	1.9%	1.9%	3.0%	1.9%

Interest Expense	(69)	(60)	(81)	(171)	(208)	(208)	(171)	(208)
Pre-tax Income	706	1,313	1,102	130	(11)	(11)	130	(11)
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0
Provision for Taxes	(242)	(403)	(252)	(50)	12	12	(50)	12
Net Income to Company	464	910	850	80	1	1	80	1
% Margin	4.8%	9.4%	9.1%	0.8%	0.0%	0.0%	0.8%	0.0%

Minority Interest in Earnings	(2)	(2)	(2)	(3)	(1)	(1)	(3)	(1)
Net Income to Stockholders	462	908	848	77	0	0	77	0

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0

Net Income to Common	462	908	848	77	0	0	77	0
% Margin	4.8%	9.4%	9.1%	0.8%	0.0%	0.0%	0.8%	0.0%

As Reported
Basic EPS (Continuing Ops)	0.00	0.00	1.97	0.18	0.00	0.00	0.18	0.00
Diluted EPS (Continuing Ops)	0.00	0.00	1.97	0.18	0.00	0.00	0.18	0.00

WA Basic Shares Out.	0.00	0.00	429.90	429.90	430.20	430.20	429.90	430.20
WA Diluted Shares Out.	0.00	0.00	429.90	431.20	434.00	434.00	431.20	434.00

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	706	1,313	1,102	130	(11)	(11)	130	(11)
Addback: Net Interest Expense	69	60	81	171	208	208	171	208
Addback: Other Non Operating Expenses, Total	27	21	38	64	114	114	64	114
Addback: Depreciation & Amortization	648	446	421	419	427	427	419	427
Addback: Restructuring Charges	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0
Addback: Asset Writedown	0	0	0	0	0	0	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	18	10	(4)	(4)	10	(4)
Adjusted EBITDA	1,450	1,840	1,660	794	734	734	794	734
% Margin	15.0%	19.0%	17.8%	8.0%	7.1%	7.1%	8.0%	7.1%

Adjusted EBIT	802	1,394	1,239	375	307	307	375	307
% Margin	8.3%	14.4%	13.3%	3.8%	3.0%	3.0%	3.8%	3.0%

Adjusted Net Income Reconciliation
Net Income to Company	464	910	850	80	1	1	80	1
Addback: Unusual Items	0	0	18	10	(4)	(4)	10	(4)
Less: Tax Benefit of Unusual Items (26%)	0	0	(5)	(3)	1	1	(3)	1
Adjusted Net Income	464	910	863	87	(2)	(2)	87	(2)
% Margin	4.8%	9.4%	9.3%	0.9%	0.0%	0.0%	0.9%	0.0%

Laadfout

Sandoz Group AG

OTCPK:SDZXF

Zwitserland / Gezondheidszorg / Farmaceutica

Historische financiële data 5 J